Nektar Therapeutics (NKTR) Return on Sales (QoQ) (2010 - 2026)
Nektar Therapeutics (NKTR) Return on Sales (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Nektar Therapeutics | 1.75 Bn | 1.18 Bn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.00 |
| Dec 31, 2025 | 3.00 |
| Sep 30, 2025 | 1.00 |
| Jun 30, 2025 | 1.00 |
| Mar 31, 2025 | -6.00 |
| Dec 31, 2024 | 3.00 |
| Sep 30, 2024 | 1.00 |
| Jun 30, 2024 | -1.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 1.00 |
| Jun 30, 2023 | 4.00 |
| Mar 31, 2023 | -7.00 |
| Dec 31, 2022 | 3.00 |
| Sep 30, 2022 | 5.00 |
| Jun 30, 2022 | -4.00 |
| Mar 31, 2022 | -19.00 |
| Dec 31, 2021 | 20.00 |
| Sep 30, 2021 | -1.00 |
| Jun 30, 2021 | 1.00 |